CellSeed Inc. engages in the cell sheet regenerative medicine business in Japan. It is involved in the commercializing regenerative medicine using cell sheets. The company also offers cell cultureware services, and contract development and manufacturing services; UpCell, a temperature-responsive cell cultureware for cell sheet engineering; RepCell for cell collection; and HydroCell, a low cell binding cultureware. In addition, it provides ThermoPlate III, a heating element; cellZscope, an automated cell monitoring systems; and cell sheet support products. The company was incorporated in 2001 and is headquartered in Tokyo, Japan.
Metrics to compare | 7776 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship7776PeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −9.4x | −0.5x | |
PEG Ratio | 0.00 | −0.20 | 0.00 | |
Price/Book | 0.0x | 4.6x | 2.6x | |
Price / LTM Sales | 0.0x | 73.1x | 3.3x | |
Upside (Analyst Target) | 0.0% | 83.2% | 48.1% | |
Fair Value Upside | Unlock | 7.7% | 7.7% | Unlock |